-
FDA names Beta Bionics’ pancreas tech a breakthrough device
This is SUPER cool! Good job Beta Bionics! Dive Brief: Boston-based medtech Beta Bionics said Tuesday it received priority review from FDA as part of the Breakthrough Devices Program for its iLet system, which uses mathematical dosing algorithms to automatically control blood sugar levels in people with diabetes. The technology,…
-
Despite ‘24/7 disease,’ Cory Conacher is a professional hockey success story
When a teammate found him, Cory Conacher was dragging his feet down the hotel hallway, walking aimlessly and speaking nonsensically. He was in his underwear and sweating. It was the middle of the night. Conacher, a then-21-year-old at his first pro hockey camp, looked like someone who’d been partying too…
-
FDA OKs First-Ever Nasal Glucagon for Severe Hypos in Diabetes
The US Food and Drug Administration (FDA) has approved the first nasally administered glucagon product (Baqsimi, Eli Lilly and Co) for the treatment of severe hypoglycemia for patients aged 4 years or older who have diabetes. The nasal powder is the first licensed glucagon product that is not delivered by…
